Hematological parameters as prognostic biomarkers in patients with cardiovascular diseases.

Hematological parameters as prognostic biomarkers in patients with cardiovascular diseases. Curr Cardiol Rev. 2019 Feb 25;: Authors: Monteiro Júnior JGM, de Oliveira Cipriano Torres D, Filho DCS Abstract Cardiovascular diseases are the major causes of preventable health loss from disease in the world and leads to functional disturbances including hematological parameters. The inflammatory and hypoxemic nature in cardiovascular diseases causes a stimulus in the bone marrow and, depending on the intensity of this stimulus, there are a release of immature cells or increase of other cells in the bloodstream. Therefore, their presence in the circulation are important variables used to diagnose, stratify and predict diseases. In the last five decades, with the advent of automated counting of immature cells in the peripheral blood, the hemogram was transformed into a clinical tool of great importance in hospital surveillance for demonstrating this daily variability in the hematopoietic response according to the existing injury in the patient. Studies have shown that the presence of nucleated red blood cells and increases in mean platelet volume, immature granulocytes and neutrophil to lymphocyte ratio in the systemic circulation are independent prognostic biomarkers. This review article has as main objective to demonstrate the association of these hematological parameters to cardiovascular diseases, emphasizing their importance in clinical...
Source: Current Cardiology Reviews - Category: Cardiology Tags: Curr Cardiol Rev Source Type: research